Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2019-07-13 2019-07-12
Drug Identification Number 02241047 02241047
Brand name VARILRIX VARILRIX
Common or Proper name Varicella virus vaccine, live, attenuated (Oka-strain) Varicella virus vaccine, live, attenuated (Oka-strain)
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients WATER VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED WATER VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 0.5ML 2000UNIT 0.5ML 2000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10's 10's
ATC code J07BK J07BK
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-04-24 2019-04-24
Estimated end date 2019-07-12 2019-07-12
Actual end date 2019-07-12 2019-07-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100. Delay in supply of GSK Diluent (packs of 10s) required for use with vaccine. Alternate supply of GSK Diluent available in packs of 100.
Health Canada comments